DROPPING TODAY Biotechnology $355M Cap Quant: HOLD

Why Is DiaMedica Therapeutics Inc. (DMAC) Stock Down Today?

Updated Nov 16, 2026 8:00 PM ET · Prev Close $8.79

Pro Workspace
Last Session Price
$8.41 -4.27%
-$0.38 vs $8.79 prior close
Intraday Range
$8.29 – $9.30
Open $8.65
Relative Volume
0.59x Avg
120,474 sh
52-Week Range
$5.25 – $11.00
Benchmark Alpha
-2.38% vs SPY
-1.85% vs QQQ
20-Session Trend -2.9%

Primary Move Catalyst & Conviction

65% Signal Conviction
SECTOR 65% Driver Weight

Pharmaceuticals & Therapeutics sector moving together

This appears to be a sector-wide move. The Pharmaceuticals & Therapeutics sector is down 3.6% on average.

Volume Confirmation
LOW VOLUME (0.59x) Unconfirmed
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 65%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

DMAC lagging the S&P 500 by -2.38%
DMAC Session
-4.27%
$8.41
S&P 500 (SPY)
-1.89%
$740.11
Nasdaq 100 (QQQ)
-2.42%
$663.44
Healthcare (XLV)
-0.38%
$188.14
Alpha vs SPY: -2.38% Alpha vs QQQ: -1.85% Alpha vs XLV: -3.89%
Peer Group: Pharmaceuticals & Therapeutics (-3.6% avg) Lagging peers by -0.7%

Options Flow & Execution Desk

Bullish Flow · P/C 0.05
Call Volume
15,254
Contracts
Put Volume
735
Contracts
Put / Call Ratio
0.05
15,989 total vol
Implied Volatility
169.2%
Chain avg IV

Recent DMAC Catalyst Headlines

Verified Wire
DiaMedica Therapeutics Q3 Earnings Call Highlights

DiaMedica Therapeutics Nasdaq Dmac expects a key interim analysis of its acute ischemic stroke trial in the first quarter of 2027, after reaching the required enrollment threshold in October, executives said on the compa

Yahoo Finance · Nov 13, 2026

1–3 Day Expected Range & Key Level

45% Follow-Through
Lower Bound
$8.16
Short-term support band
Upper Bound
$8.58
Short-term resistance band
Key Inflection Level
$7.99 (support)

Watch for breakdown below $8.41

Technical Regime (DMAC)

MIXED MA TREND
RSI (14)
46.0
Bearish
20-Day SMA
$9.24
Below 20d
50-Day SMA
$8.24
Above 50d
MACD Signal
Bearish
MACD 0.26
ADX (14)
27.0
Strong trend
10d Momentum
-0.73
Soft 10-day momentum

1-Year Historical Move Analogs

43 Events

Sessions in the past year where DMAC moved >3.0% down:

Continuation Rate
46.5%
20/43 sessions
Avg Next-Day Move
+0.25%
T+1 session return
Last analog: Nov 13, 2026 (-5.8%) → Next session: -4.3%

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

SCAG announced a strategic cooperation agreement with China Huaye Group. The agreement is bullish for SCAG as it expands their reach into the Chinese market.

Reddit communities: 1 comment (Neutral)

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a reco...

Sector
Healthcare
Market Cap
$355M
Employees
28

Get Instant DMAC Catalyst Alerts

Receive an email alert when DMAC triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

DMAC Session & Catalyst FAQ

Why is DMAC stock down today?

This appears to be a sector-wide move. The Pharmaceuticals & Therapeutics sector is down 3.6% on average.

Is DMAC stock a buy or sell right now?

Today's session carries a 65% catalyst conviction score on 0.59x relative volume (low participation). Our multi-factor model currently rates DMAC as HOLD. Review full valuation, quality, and timing signals on the DMAC Buy or Sell Decision Brief →

What is DMAC's intrinsic value and expected trading range?

At $8.41, DMAC's modeled 1-to-3 session range is $8.16 – $8.58, with a key inflection level at $7.99 (support). Compare current price against multi-year cash flow projections in the DMAC Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for DMAC?

RSI at 46.0 reflects soft below-midline momentum. DMAC trades at $8.41 relative to its 20-day SMA ($9.24) and 50-day SMA ($8.24), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs